XASX
SKN
Market cap7mUSD
Oct 09, Last price
0.00AUD
1D
0.00%
1Q
-57.14%
IPO
-98.21%
Name
Skin Elements Ltd
Chart & performance
P/E
—
P/S
44.83
EPS
—
Div yield, %
—
Shrs. gr., 5y
42.23%
Rev. gr., 5y
-4.29%
Revenues
232k
-50.64%
Net income
-5m
L+205.30%
CFO
-3m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in West Perth, Australia, Skin Elements Limited is a natural skincare enterprise established in 2015. The company specializes in the development, manufacturing, distribution, and retail of natural, organic, health, and wellness products throughout Australia. Its product offerings include SuprCuvr, a disinfectant spray; Soléo Organics sunscreen; Papaya Activs, formulated for skin condition treatment; and Elizabeth Jane, designed for sensitive skin.
Key people
Craig Piercy
Chief Financial Officer · since 2020
Peter Malone
Executive Chairman of the Board, Chief Executive Officer, Managing Director · since 2015
Leo Fung
Chief Technical Advisor
Company Secretary, Non-Executive Director · since 2023
Filippo Giglia
Non-Executive Independent Director · since 2023
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||